KemPharm
KMPH
$5.81
Share price
-0.34%
Change (1 day)
6.61%
Change (1 year)
Categories
Revenue for KemPharm (KMPH)
Revenue in 2022 (TTM): $10.45 M
According to KemPharm's latest financial reports the company's current revenue (TTM
) is $10.45 M.
In 2021 the company made a revenue of $28.65 M an increase over the years 2020 revenue that were of $13.28 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for KemPharm from 2014 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $10.45 M | -63.5% |
| 2021 | $28.65 M | 115.61% |
| 2020 | $13.28 M | 3.5% |
| 2019 | $12.83 M | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Theravance Biopharma
TBPH | $57.42 M | 449.09% | Cayman Islands |
 Jazz Pharmaceuticals JAZZ | $3.84 B | 36,650.57% | 🇮🇪 Ireland |
 ANI Pharmaceuticals ANIP | $0.48 B | 4,554.96% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $19.59 M | 87.34% | 🇺🇸 USA |